scholarly journals Faculty Opinions recommendation of Lorlatinib in non-small-cell lung cancer with ALK or ROS1 rearrangement: an international, multicentre, open-label, single-arm first-in-man phase 1 trial.

2017 ◽  
Author(s):  
Nico van Zandwijk
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Phase 1 ◽  
Small Cell ◽  
Small Cell Lung ◽  
Open Label ◽  
Phase 1 Trial ◽  
Ros1 Rearrangement

scholarly journals Lorlatinib in non-small-cell lung cancer with ALK or ROS1 rearrangement: an international, multicentre, open-label, single-arm first-in-man phase 1 trial

2017 ◽  
Vol 18 (12) ◽  
pp. 1590-1599 ◽  
Author(s):  
Alice T Shaw ◽  
Enriqueta Felip ◽  
Todd M Bauer ◽  
Benjamin Besse ◽  
Alejandro Navarro ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Phase 1 ◽  
Small Cell ◽  
Small Cell Lung ◽  
Open Label ◽  
Phase 1 Trial ◽  
Ros1 Rearrangement

Crizotinib in patients (pts) with MET-amplified non-small cell lung cancer (NSCLC): Updated safety and efficacy findings from a phase 1 trial.

2018 ◽  
Vol 36 (15_suppl) ◽  
pp. 9062-9062 ◽  
Author(s):  
D. Ross Camidge ◽  
Gregory Alan Otterson ◽  
Jeffrey W. Clark ◽  
Sai-Hong Ignatius Ou ◽  
Jared Weiss ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Phase 1 ◽  
Small Cell ◽  
Small Cell Lung ◽  
Safety And Efficacy ◽  
Phase 1 Trial

scholarly journals Nivolumab alone and nivolumab plus ipilimumab in recurrent small-cell lung cancer (CheckMate 032): a multicentre, open-label, phase 1/2 trial

2016 ◽  
Vol 17 (7) ◽  
pp. 883-895 ◽  
Author(s):  
Scott J Antonia ◽  
José A López-Martin ◽  
Johanna Bendell ◽  
Patrick A Ott ◽  
Matthew Taylor ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Phase 1 ◽  
Small Cell ◽  
Small Cell Lung ◽  
Open Label ◽  
Open Label Phase

Pembrolizumab in patients with advanced non-small-cell lung cancer (KEYNOTE-001): 3-year results from an open-label, phase 1 study

2019 ◽  
Vol 7 (4) ◽  
pp. 347-357 ◽  
Author(s):  
Natasha B Leighl ◽  
Matthew D Hellmann ◽  
Rina Hui ◽  
Enric Carcereny ◽  
Enriqueta Felip ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Phase 1 ◽  
Small Cell ◽  
Small Cell Lung ◽  
Open Label ◽  
Phase 1 Study ◽  
Open Label Phase

Pralsetinib for RET fusion-positive non-small-cell lung cancer (ARROW): a multi-cohort, open-label, phase 1/2 study

2021 ◽  
Author(s):  
Justin F Gainor ◽  
Giuseppe Curigliano ◽  
Dong-Wan Kim ◽  
Dae Ho Lee ◽  
Benjamin Besse ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Phase 1 ◽  
Small Cell ◽  
Small Cell Lung ◽  
Open Label ◽  
Open Label Phase
Sign in / Sign up

Export Citation Format

Share Document